Altimmune, Inc.

Altimmune, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative next-generation peptide-based therapeutics. The company is headquartered in Gaithersburg, Maryland, and has a strong management team with expertise in scientific and business operations, compound invention, and clinical development. Their primary focus is the development of pemvidutide, a GLP-1/glucagon dual receptor agonist for the treatment of obesity and metabolic dysfunction-associated steatohepatitis (MASH). Pemvidutide has shown promising results in clinical trials, demonstrating significant weight loss, reductions in triglycerides, LDL cholesterol, liver fat content, and blood pressure with a favorable safety profile.

Altimmune is committed to developing innovative therapies that address unmet medical needs in obesity and liver disease. They believe in strategic partnerships to break barriers to innovation and continuously evaluate partnership opportunities. Altimmune offers exciting career opportunities for talented individuals who share their passion for science and developing novel therapies.

Altimmune, Inc. has a strong emphasis on retaining top talent by offering a work environment that encourages innovation, recognizes achievements, and provides opportunities for advancement. While specific job postings may indicate flexibility, the company website does not mention any specific details about job flexibility, such as remote work options or flexible schedules.

Altimmune is a clinical-stage biopharmaceutical company focused on developing innovative next-generation peptide-based therapeutics for the treatment of obesity and metabolic dysfunction-associated steatohepatitis (MASH). Their lead product, pemvidutide, is a GLP-1/glucagon dual receptor agonist, which works by mimicking the effects of diet and exercise on weight loss and liver health. With pemvidutide, Altimmune aims to address the growing global health challenges of obesity and liver disease, offering potential solutions for a significant population struggling with these conditions.

Altimmune fosters a culture of innovation, resourcefulness, and enthusiasm, valuing a diverse workforce that shares a passion for science and a drive to develop novel immune-modulating therapies and treatments for liver diseases. The company encourages employees to be decisive, recognize achievements, and provide opportunities for advancement.

Altimmune is committed to fostering a diverse, equitable, and inclusive workplace. They actively recruit and retain a talented workforce from diverse backgrounds, encouraging innovation, recognizing achievements, and offering opportunities for advancement. They provide equal employment opportunities to all employees and applicants, prohibiting discrimination and harassment of any type without regard to race, color, religion, age, sex, national origin, disability status, genetics, protected veteran status, sexual orientation, gender identity or expression, or any other characteristic protected by federal, state, or local laws.